Multiple central nervous system targets for eliciting beneficial effects on memory and cognition

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 2, 2000, Pages 438-446

  Buccafusco, J J ^a   Terry A V , Jr ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 3 (2 PYRROLIDINYLMETHOXY)PYRIDINE; 3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; 3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; 4 [[2 (1 METHYL 2 PYRROLIDINYL)ETHYL]THIO]PHENOL; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BENZOQUINONE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; CYCLOSERINE; DONEPEZIL; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; EXCITATORY AMINO ACID; GLYCINE DERIVATIVE; HERBACEOUS AGENT; INSULIN; MECAMYLAMINE; NEUROTRANSMITTER RECEPTOR; NICOTINE; NORADRENALIN; OCTREOTIDE; PEPTIDE; PHYSOSTIGMINE; SEROTONIN; SEROTONIN AGONIST; TACRINE; UNINDEXED DRUG; VELNACRINE; XANTHINE DERIVATIVE;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; CELL LOSS; CHOLINERGIC NERVE CELL; COGNITION; DEGENERATIVE DISEASE; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; FOREBRAIN; HUMAN; MEMORY; MONKEY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TASK PERFORMANCE;

AGING; ANIMAL; COGNITION; COGNITION DISORDERS; HUMAN; MEMORY; MEMORY DISORDERS; NEURONS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0033780434     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. 3 receptor antagonists on cognitive performance in aged monkeys
2. Sensitivity to ageing of the limbic dopaminergic system: A review
3. Identification of angintensin II receptor subtypes in human brain
4. Angiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro
5. The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist
6. d-Cycloserine, a novel cognitive enhancer, improves spatial memory in aged rats
7. Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease
8. Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21. In vitro and in vivo
9. Neuropharmacologic and behavioral actions of clonidine: Interactions with central neurotransmitters
10. Isoarecolone-induced memory enhancement in monkeys: Role of nicotinic receptors
11. Differential improvement in memory-related task performance to nicotine by aged male and female rhesus monkeys
12. Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: A novel cholinergic channel activator for memory enhancement
13. Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys
14. Combining tacrine with milameline reverses a scopolamine induced impairment of continuous performance in rhesus monkeys
15. Serotonergic modulation of cholinergic function in the central nervous system: Cognitive implications
16. NMDA receptors - Their role in long-term potentiation
17. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose
18. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys
19. Angiotensin II blocks hippecampal long-term potentiation
20. Visual recognition memory in squirrel monkeys: Effects of serotonin antagonists on baseline and hypoxia-induced performance deficits
21. The role of excitotoxicity in neurodegenerative disease: Implications for therapy
22. Angiotensin converting enzyme inhibitors as potential cognitive enhancing agents
23. Beneficial effects of glycine (bioglycin) on memory and attention in young and middle-aged adults
24. The cholinergic hypothesis of Alzheimer's disease: A review of progress
25. 2 receptor subtype levels in brain regions from patients with neurodegenerative disorders
26. Alzheimer's disease and other dementing disorders in adults
27. Milacemide, a glycine prodrug, enhances performance of learning tasks in normal and amnestic rodents
28. Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats
29. Velnacrine maleate improves delayed matching to sample performance by aged monkeys
30. Effect of tacrine on behavioral symptoms in Alzheimer's disease: An open label study
31. Therapeutic potential of histamine H3 receptor agonists and antagonists
32. Characterization of the nociceptive and toxic effects of α7 nicotinic receptor activation in PC12 cells
33. Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease
34. Local infusion of an α-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys
35. A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R
36. Review 5-HT system and cognition
37. Very mild Alzheimer's disease: Informant based clinical, psychometric, and pathologic distinction from normal aging
38. Muscarinic M1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain
39. The efficacy of Ginkgo biloba on cognitive function in Alzheimer's disease
40. Effects of AF102B and tacrine on delayed match-to-sample in monkeys
41. Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?
42. Effects of peptides: A crosslisting of peptides and their central actions published in the journal Peptides from 1994 through 1998
43. Central histaminergic system and cognition
44. Symposium overview: The use of delayed matching-to-sample procedures in studies of short-term memory in animals and humans
45. Acute effects of the selective cholinergic channel activator ABT-418 in Alzheimer's disease
46. Histaminergic neurons facilitate social memory in rats
47. Improvement in accuracy on a delayed recall task by aged monkeys and mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418
48. Facilitation of acetylcholine release and cognitive performance by an M2-muscarinic receptor antagonist in aged memory-impaired rats
49. THA improves word priming and clonidine enhances fluency and working memory in Alzheimer's disease
50. Arousal systems and attention
51. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomized controlled trial
52. d-Cycloserine enhances implicit memory in Alzheimer patients
53. The α-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys
54. 4 receptor agonist, RS 17017
55. Dose-specific improvements in memory-related task performance by rats and aged monkeys administered the nicotinic-cholinergic antagonist mecamylamine
56. 3 receptor antagonist, RS-56812, enhances delayed matching performance in monkeys
57. Ranitidine analog, JWS-USC-75IX, enhances memory-related task performance in rats
58. Effects of concomitant cholinergic and adrenergic stimulation on learning and memory performance by young and aged monkeys
59. A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease
60. Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease
61. Important roles for angiotensin III and IV in the brain renin-angiotensin system
62. Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy